Insider trade

BioMarin Pharmaceutical (BMRN): Officer sold ~$997K

Charles Greg Guyer, Officer at BioMarin Pharmaceutical, sold ~$997K of BioMarin Pharmaceutical shares.

~$997K
Approx. value · 16K sh @ $60.46
80K
Holds after · shares reported
Traded
Mar 11, 2026
Filed
Mar 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jan 26, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  3. Feb 12, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  4. Feb 23, 2026Company filing · Form 8-K · ResultsReported its results
  5. Feb 26, 2026Insider · 2 peopleInsiders: 2 sales (~$2.0M)
  6. Mar 11, 2026 · this disclosureInsiderOfficer sold ~$997K of BMRN shares in the open market

What came next

  1. Apr 27, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 2 more items)“The information set forth in the “Introductory Note” above is incorporated into this Item 2.01 by reference.”
  2. May 4, 2026Company filing · Form 8-K · ResultsReported its results
  3. May 7, 2026InsiderOfficer sold ~$177K of BMRN shares in the open market
  4. Jun 2, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 2, 2026, BioMarin Pharmaceutical Inc. (BioMarin or the Company) held its 2026 Annual Meeting of Stockholders (the Annual Meeting).”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for BioMarin Pharmaceutical

For BioMarin Pharmaceutical, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BMRN page.

Other recent filings by Charles Greg Guyer, EVP, Chief Technical Officer

The full history of Charles Greg Guyer, EVP, Chief Technical Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which BioMarin Pharmaceutical (BMRN) insider traded, and how much?

Charles Greg Guyer, Officer at BioMarin Pharmaceutical, sold ~$997K of BioMarin Pharmaceutical shares. 16K shares at $60.46.

When did it happen, and when was it made public?

Traded: Mar 11, 2026. Filed: Mar 12, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about BioMarin Pharmaceutical recently?

For BioMarin Pharmaceutical, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the BMRN page.

Does this mean BMRN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at BioMarin Pharmaceutical

Everything OQRO holds on this company is on its BMRN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data